Penumbra Inc (NYSE:PEN)
| 224.20 Delayed Data As of 3:59pm ET |  +1.01 / +0.45%Today’s Change | 180.93 Today|||52-Week Range 348.67 | +0.78% Year-to-Date |
Latest PEN News | Press Releases
| Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report? Dec 06 / Zacks.com - Paid Partner Content | Penumbra (PEN) Enrolls First Patient in Landmark STORM-PE Trial Nov 30 / Zacks.com - Paid Partner Content |
| Wall Street Analysts See a 26.89% Upside in Penumbra (PEN): Can the Stock Really Move This High? Nov 30 / Zacks.com - Paid Partner Content | Penumbra's (PEN) Expansion Moves, New Launches Aid Growth Nov 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 223.19 |
| Today’s open | 223.60 |
| Day’s range | 221.14 - 224.45 |
| Volume | 279,165 |
| Average volume (3 months) | 408,383 |
| Market cap | $8.8B |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | -136.81% |
| Earnings growth (this year) | +891.98% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +13.32% |
| P/E ratio | 213.4 |
| Price/Sales | 9.94 |
| Price/Book | 8.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SWAVShockwave Medical In... | -0.80 | -0.46% |
| TFXTeleflex Inc | -1.56 | -0.67% |
| ---- | ||
| HAEHaemonetics Corp | +1.56 | +1.87% |
Data as of 4:00pm ET, 12/08/2023
Financials
| Next reporting date | February 27, 2024 |
| EPS forecast (this quarter) | $0.61 |
| Annual revenue (last year) | $847.1M |
| Annual profit (last year) | -$2.0M |
| Net profit margin | -0.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Alameda, California |
Forecasts
